Adrian Woolfson
Direktor/Vorstandsmitglied bei ImmunoSCAPE Pte Ltd.
Profil
Adrian Woolfson is currently the Director at ImmunoSCAPE Pte Ltd.
He previously worked as the Head-Global Clinical at Pfizer Inc. from 2015 to 2018, as the Executive Vice President-Research & Development at Sangamo Therapeutics, Inc. from 2019 to 2020, and as the Chief Medical Officer at Nouscom AG in 2018.
Dr. Woolfson received his undergraduate degree from the University of Oxford in 1995 and his doctorate degree from the University of Cambridge in 1992.
Aktive Positionen von Adrian Woolfson
| Unternehmen | Position | Beginn |
|---|---|---|
ImmunoSCAPE Pte Ltd.
 ImmunoSCAPE Pte Ltd. BiotechnologyHealth Technology ImmunoSCAPE Pte Ltd. develops immunotherapy and leveraging therapies. The firm focuses on immunotherapy and leveraging a unique high-dimensional immune profiling Platform. The company was founded by Choon-Peng Ng, Alessandra Nardin, Michael Fehlings and Evan Newell in 2016 and is headquartered in Singapore. | Direktor/Vorstandsmitglied | 28.07.2021 |
Ehemalige bekannte Positionen von Adrian Woolfson
| Unternehmen | Position | Ende |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 24.06.2020 |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2018 |
| PFIZER, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
Ausbildung von Adrian Woolfson
| University of Oxford | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Health Technology |
ImmunoSCAPE Pte Ltd.
ImmunoSCAPE Pte Ltd. BiotechnologyHealth Technology ImmunoSCAPE Pte Ltd. develops immunotherapy and leveraging therapies. The firm focuses on immunotherapy and leveraging a unique high-dimensional immune profiling Platform. The company was founded by Choon-Peng Ng, Alessandra Nardin, Michael Fehlings and Evan Newell in 2016 and is headquartered in Singapore. | Health Technology |
